The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer

NCT00243347 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma
Non-Small-Cell Lung Carcinoma
Head and Neck Neoplasms

Interventions

DRUG: AZD2171

Sponsor

AstraZeneca